Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Mito Rx Appoints Alison Strutt As Chief Financial Officer and László Tankó As Chief Marketing Officer

PRIVATEJun 09, 2026•7 days ago

Position

Chief Marketing Officer

Company

MitoRx Therapeutics

László Tankó

OxfordBiotechnologyHealth CareTherapeutics

Description

MitoRx Therapeutics has appointed Alison Strutt as CFO and László Tankó as Consultant CMO to enhance its leadership team. These appointments are part of the company's strategy to advance the obesity drug MTRX31 into clinical trials.

Company Information

Company

MitoRx Therapeutics

Location

Oxford, England, United Kingdom

About

MitoRx Therapeutics is a pre-clinical stage rare disease biotech company aiming to become the leading global developer of medicines arresting the progression of degenerative diseases driven by mitochondrial dysfunction, with a focus on neuromuscular disease, metabolic disease and neurodegenerative disease.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for MitoRx Therapeutics's next move

Learn about Strategic plan

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months